Toward an Understanding of the Chemical Etiology for DNA Minor‐Groove Recognition by Polyamides

Helvetica Chimica Acta - Tập 85 Số 12 - Trang 4485-4517 - 2002
Michael A. Marques1, Raymond M. Doss1, Adam R. Urbach1, Peter B. Dervan1
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125

Tóm tắt

Abstract

Crescent‐shaped polyamides composed of aromatic amino acids, i.e., 1‐methyl‐1H‐imidazole Im, 1‐methyl‐1H‐pyrrole Py, and 3‐hydroxy‐1H‐pyrrole Hp, bind in the minor groove of DNA as 2 : 1 and 1 : 1 ligand/DNA complexes. DNA‐Sequence specificity can be attributed to shape‐selective recognition and the unique corners or pairs of corners presented by each heterocycle(s) to the edges of the base pairs on the floor of the minor groove. Here we examine the relationship between heterocycle structure and DNA‐sequence specificity for a family of five‐membered aromatic amino acids. By means of quantitative DNase‐I footprinting, the recognition behavior of polyamides containing eight different aromatic amino acids, i.e., 1‐methyl‐1H‐pyrazole Pz, 1H‐pyrrole Nh, 5‐methylthiazole Nt, 4‐methylthiazole Th, 3‐methylthiophene Tn, thiophene Tp, 3‐hydroxythiophene Ht, and furan Fr, were compared with the polyamides containing the parent‐ring amino acids Py, Im, and Hp for their ability to discriminate between the four WatsonCrick base pairs in the DNA minor groove. Analysis of the data and molecular modeling showed that the geometry inherent to each heterocycle plays a significant role in the ability of polyamides to differentiate between DNA sequences. Binding appears sensitive to changes in curvature complementarity between the polyamide and DNA. The Tn/Py pair affords a modest 3‐fold discrimination of T⋅A vs. A⋅T and suggests that an S‐atom in the thiophene ring prefers to lie opposite T not A.

Từ khóa


Tài liệu tham khảo

10.1073/pnas.82.5.1376

10.1021/bi00371a024

10.1021/ja00160a016

10.1016/S0968-0896(01)00262-0

10.1021/ja00049a006

10.1038/nsb0298-104

10.1038/35106

10.1126/science.282.5386.111

10.1002/jmr.300020206

10.1021/jo991571g

10.1016/S0968-0896(00)00219-4

10.1016/S0968-0896(00)00182-6

10.1021/ja00087a088

10.1038/382559a0

10.1021/ja960726o

10.1016/S1097-2765(00)00099-X

10.1021/ja9930667

P. B. Dervan A. R. Urbach

10.1016/S0022-2836(02)00430-8

10.1021/ja960720z

10.1002/jhet.5570320431

Rao K. E., 1990, Anti‐Cancer Drug Des., 5, 3

10.1080/00397917908064186

10.1016/S0076-6879(01)40436-8

‘Spartan Essential' Wavefunction Inc. 1991–2001.

10.1021/ja983206x

10.1073/pnas.93.14.6981

10.1021/ja983671u

10.1006/jmbi.1999.3364

10.1073/pnas.081070798

10.1016/S0969-2126(97)00255-4